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Abstract
Short poly(C)-tract Mengoviruses have proven vaccine efficacy in many species of animals. A novel vector for the delivery of foreign
proteins was created by insertion of a second autoproteolytic primary cleavage cassette linked to a multiple cloning site (MCS) into an
attenuated variant of Mengo. Nineteen cDNAs from foreign sequences that ranged from 39 to 1653 bases were cloned into the MCS. The
viral reading frame was maintained and translation resulted in dual, autocatalytic excision of the foreign peptides without disruption of any
Mengo proteins. All cDNAs except those with the largest insertions produced viable virus. Active proteins such as GFP, CAT, and SIV p27
were expressed within infected cells. Relative to parental Mengo, the growth kinetics and genetic stability of each vector was inversely
proportional to the size of the inserted sequence. While segments up to 1000 bases could be carried, inserts greater than 500–600 bases were
usually reduced in size during serial passage. The limit on carrying capacity was probably due to difficulties in virion assembly or particle
stability. Yet for inserts less than 500–600 bases, the Mengo vectors provided an effective system for the delivery of foreign epitopes into
cells and mice.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Advances in molecular biology and genetic engineering
have led to the increasing use of viruses as live vaccine
vectors. Multivalent vectors have been created from strains
of vaccinia, adeno-, polio, and many other viruses by clon-
ing exogenous genes or foreign epitope-encoding segments
into viral DNAs or cDNAs (Rooney et al., 1988; Sanz-Parra
et al., 1999; Crotty et al., 1999). The idea behind such
constructions is that during infection, the foreign antigens
will be coexpressed and presented to the host’s immune
system along with native viral proteins, and within such
contexts, the antigens are potentially capable of eliciting
protective responses and immunological memory. The sin-
gle-stranded, positive-sense RNA picornaviruses are espe-
cially attractive vector candidates (Mandl et al., 1998;
Crotty et al., 1999; Andino et al., 1994). The genomes are
encapsidated by nonenveloped protein shells that are easily
recognized and neutralized by antibodies, as evidenced by
successful vaccines against polio (Osorio et al., 1996a),
foot-and-mouth disease (Brown, 1992), hepatitis A (Pelle-
grini et al., 1993), and encephalomyocarditis virus (EMCV)
(Osorio et al., 1996a). Picornaviruses undergo short, lytic
cytoplasmic life cycles that do not require integration or
transformation events in the nucleus (Rueckert, 1996).
Moreover most picornaviruses have cDNA reverse genetics
systems for the facile development and testing of multiple
genome configurations with the best vaccine potential.
Our laboratory focuses on the Cardioviruses, EMCV,
and Mengo virus. Although rodents are the most prevalent
natural hosts and the sources of nearly all wild-type epizoot-
ics (Kissling et al., 1956; Wells et al., 1989; Gainer, 1967),
these serologically related pathogens are unusual among
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picornaviruses, and indeed among most positive-strand
RNA viruses, in that they are infectious to diverse species of
mammals without requiring extensive cell passage or host-
specific adaptation. Depending upon the dose and route of
infection, wild-type strains of EMCV are highly virulent in
primates, pigs, elephants, mice, rats, voles, and many other
animals. Tests with engineered Mengo and EMC viruses
point to an unusual homopolymeric polycytidine tract
within the 5 untranslated region as the major pathogenic
determinant. Truncation or deletion of the native Mengo
segment (C44UC10) generates genetically stable attenuated
viruses with significantly decreased virulence (Duke et al.,
1990). Recombinant virus vMC0, with a complete poly(C)
deletion, has a 50% lethal dose (LD50) in mice that is at least
108–1011 times higher than for wild-type Mengo-M (Martin
et al., 1996). Inoculation of animals with this or similar
recombinant strains induces high titers of neutralizing anti-
bodies and prophylactic protection against disease (Osorio
et al., 1996b). Mengo vMC0 has proven to be a safe and
effective cardioviral vaccine in virtually all species of wild
and domesticated animals that are commonly exposed to
EMCV-like cardioviruses (Osoriov et al., 1996a; Dethlefs et
al., 1997).
Previous attempts at developing recombinant vectors
based on short poly(C) tract Mengo viruses fused the for-
eign epitopes into the 69 amino acid Leader protein at the
N-terminus of the viral polypeptide. Van der Ryst and
co-workers failed to detect significant insert-specific im-
mune responses after vaccination of macaques or mice with
such constructions that carried regions of the SIV nef, gag,
pol, or HIV nef genes (Van der Ryst et al., 1998). In
contrast, Altmeyer et al. reported strong anti-HIV antibody
titers in mice and macaques, as well as cytotoxic T-lym-
phocyte (CTL) responses in mice, after immunizations with
a Mengo chimera expressing a fragment of the HIV glyco-
protein (Altmeyer et al., 1994). This group also found that
vaccination with Mengo carrying a CTL epitope from the
LCMV nucleoprotein generated potent CTL activity capa-
ble of protecting mice from lethal challenge with LCMV
(Altmeyer et al., 1995). Unfortunately, as was found with
many related polio vectors (Mueller and Wimmer, 1998;
Mattion et al., 1994, 1995), the foreign insertions in these
Mengo constructions tended to interfere with the viral rep-
lication cycle and the largest heterologous sequences were
usually deleted during viral amplification. Optimally, live
vectors should be able to carry reasonably sized foreign
genes for multiple rounds of infection, with an expectation
of genetic stability. To achieve this, we have now explored
another Mengo genome location where heterologous inser-
tions might prove less disruptive.
The Mengo polyprotein is processed cotranslationally
and posttranslationally into mature proteins by a series of
cleavage events mediated by endogenous proteases (Pal-
menberg, 1990). The cardio-, aphtho-, and erbovirus cleav-
age series are distinguished from those of the entero-,
rhino-, hepato-, and parechoviruses in that they begin with
a special cotranslational, autocatalytic reaction at the junc-
tion of the 2A and 2B proteins. This first, or primary
cleavage, is mediated by a short, self-contained amino acid
motif called the primary cleavage cassette (PCC). The N-
terminus of this element maps to amino acid 125 of the
EMCV 2A protein, the 18th amino acid before the cleavage
site (Hahn and Palmenberg, 2001). The segment ends at the
COOH side with the first amino acid of 2B and includes the
rare DvExNPG/P motif that characterizes all picornaviruses
(Hahn and Palmenberg, 2001) and type C rotaviruses (Lang-
land et al., 1994) that undergo PCC-dependent processing.
For EMCV and Mengo, the complete segment of 19 amino
acids (18 from 2A, 1 from 2B) is essential for efficient
cleavage (Hahn and Palmenberg, 2001). The primary reac-
tion fires to virtual completion within the context of a
nascent polyprotein and is a prerequisite for subsequent
processing of the upstream L-P1-2A precursor by viral
protease 3Cpro, an obligate step in the viral life cycle. We
now report the development of a viral vector based on
attenuated vMC0 and carrying duplicate copies of the PCCs
from Mengo and EMCV. The cleavage cassettes are sepa-
rated by a multiple cloning site to facilitate the insertion of
heterologous genes into cDNA. Foreign peptides flanked by
these PCCs were released during genome translation in
reactions that minimized the negative effects of foreign
inserts on viral translation and replication functions. As a
result, the effective carrying capacity of Mengo for heter-
ologous sequences is significantly improved over those vec-
tors which relied on Leader protein fusions.
Results
cDNA panel
A copy of the EMCV PCC was inserted downstream of
the natural 2A/2B junction in a Mengo cDNA that encoded
an infectious, attenuated viral strain with a deleted 5
poly(C) tract (Fig. 1). Nineteen heterologous DNA frag-
ments (Table 1), chosen for length variability, sequence
diversity, and potential protein immunogenicity, were li-
gated into the multiple cloning site (MCS) between these
cleavage cassettes. The inserted sequences maintained the
polyprotein reading frame and increased the parental vMC0
genome length [7723 bases including 23 b poly(A) tail] by
39 to 1653 bases in addition to the EMCV PCC (84 b) and
MCS (27 b). Two parallel constructions [vCM(GFP)E
and vCM(Emd)E] replaced the deleted 5 poly(C) tract
with a longer sequence (C44UC10) from vMwt virus. Cell-
free translation reactions with genome-length RNA tran-
scripts confirmed in every case that normal capsid and
noncapsid viral proteins were synthesized in their expected
ratios (15 examples are illustrated in Fig. 2). Moreover, the
processing patterns and appearance of extra bands were in
accord with those predicted if both the natural (upstream
Mengo) and the inserted (downstream EMCV) PCCs fired
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successfully during protein expression. The self-excising
peptides from constructs encoding inserts smaller than 17
kDa (e.g., Fig. 2, 4 to 13 kDa) were usually not retained by
the gels, but the larger vectors (22–48 kDa) each produced
bands consistent with their respective insert size and protein
charge. Western analyses confirmed the identity of these
bands as GFP or SIV-specific, dependent upon the sequence
(not shown).
Genome infectivity
RNA transcribed from pC0ME is 111 bases longer than
from pMC0, the infectious parental cDNA (Martin et al.,
1996), but after transfection of HeLa cells, both RNAs had
similar infectivities and gave rise to roughly equivalent
fields of uniform plaques (about 2.1 mm diameter) after 31 h
of incubation. Virus isolated from multiple, independent
C0ME plaques passaged with vigor and fidelity. Appar-
ently, the inclusion of a second functional PCC did not, by
itself, place undue selective pressure on virus fecundity and
this virus vector behaved similar to its wild-type parent in
tissue culture.
It is well known, however, that the addition of exogenous
sequences to picornavirus genomes can impair viral growth
(Mueller and Wimmer, 1998; Mattion et al., 1994, 1995).
To test the insert length restrictions within the context of
duplicate primary cleavages, RNA transcripts from the
cDNA panel were quantitated and then transfected into
HeLa cells. The specific infectivity, resultant plaque area,
and time required for CPE were characterized relative to
Fig. 1. C0M’E’ vector. The C0M’E’ vector differs from pMC0 by the inclusion of a multiple cloning site (27 b, 9 amino acids) and a primary cleavage cassette
derived from EMCV plasmid pEC9 (84 b, 28 amino acids). The Gly-Pro residues (stars) are the autocatalytic scission sites. RNA transcripts have two nonviral
G bases at the 5 end and terminate with a partial BamHI sequence after the poly(A) tail (23 b).
Table 1
Source of insert sequences
Vector Insert lengtha
(bases)
Insert identityb Fragment originc
(bases)
C0ME 6 Multiple cloning site Synthetic oligo
C0M(mal)E 39 Plasmodium yoelli circumsporozoite protein Synthetic oligo
C0M(fmd)E 81 FMDV VP1 Synthetic oligo
C0M(96)E 96 SIV p27 354–449
C0M(189)E 189 SIV p27 114–302
C0M(225)E 225 SIV p27 225–449
C0M(336)E 336 SIV p27 114–449
C0M(378)E 378 SIV p27 354–731
C0M(456)E 456 SIV p27 (7)–449
C0M(474)E 474 SIV p27 114–587
C0M(594)E 594 SIV p27 (7)–587
C0M(618)E 618 SIV p27 114–731
C0M(CAT)E 657 CAT 1–657
C0M(GFP)E 714 GFP 1–713
CM(GFP)E 714 GFP 1–713
C0M(Emd)E 720 Enhanced GFP 1–717
CM(Emd)E 720 Enhanced GFP 1–717
C0M(p27)E 738 SIV p27 (7)–731
C0M(873)E 873 GFP & SIV p27 1–129 & (7)–731
C0M(1026)E 1026 GFP & SIV p27 1–282 & (7)–731
C0M(1176)E 1176 GFP & SIV p27 1–432 & (7)–731
C0M(luc)E 1653 Firefly luciferase 1–1653
a Base length between the NheI and SunI restriction sites of vector.
b cDNA sequence(s) from which inserts were derived.
c Inclusive reading frame bases of gene fragment excised to create insert.
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C0ME transcripts (Table 2 and Fig. 3). In multiple exper-
iments with independently prepared RNA samples, the se-
quences sorted themselves into a hierarchy, correlating al-
most exactly with the length of the inserted fragment. For
inserts up to 738 bases, there was an approximate 10%
reduction in plaque area for every 75 added bases (Fig. 3).
Longer RNAs barely produced discernible plaques within
the same time frame (31 h), although after additional incu-
bation, plaque populations with heterogeneous sizes did
appear. These mixed plaque sizes were more suggestive of
reversion than a genuine phenotype. Still, except for RNA
with the largest insert, C0M(luc)E (1653 b), which never
gave plaques even after 70 h, all other transcripts produced
viable virus by 31 h, or at least showed themselves capable
of directing a minimum level of infectious progeny synthe-
sis.
The progressive reduction in plaque growth as a function
of insert size was also reflected by the RNA specific infec-
tivity and the time required for observable CPE (Table 2).
Transfection with any transcripts except C0M(luc)E even-
tually killed the monolayers, but those with the longest
insertions were always the slowest to develop CPE. Tran-
Fig. 2. Protein expression by Mengo vectors. RNA transcripts from the indicated cDNAs were used to program cell-free translation reactions in reticulocyte
extracts in the presence of [35S]Met. After fractionation by SDS–PAGE (13.5% Laemmli), the products were visualized by autoradiography. Protein markers
and the predicted sizes of the insert-directed products are indicated.
Table 2
Vector Infectivity
Vector Insert
length
(bases)
RNA
infectivitya
(PFU/100 ng)
Plaque size
(%)b
Observed
CPE (h)c
C0ME 6 160 100 24–37
C0M(mal)E 39 130 97 24–37
C0M(fmd)E 81 140 93 24–37
C0M(96)E 96 110 88 24–37
C0M(189)E 189 110 73 24–37
C0M(225)E 225 100 71 24–37
C0M(336)E 336 70 54 24–37
C0M(378)E 378 60 39 24–37
C0M(456)E 456 50 27 24–37
C0M(474)E 474 80 29 24–37
C0M(594)E 594 60 14 37–44
C0M(618)E 618 70 11 37–44
C0M(CAT)E 657 ndd 5d 45–50d
C0M(GFP)E 714 30 5 44–50
CM(GFP)E 714 30 6 37–44
C0M(Emd)E 720 50 6 50–62
CM(Emd)E 720 20 6 50–62
C0M(p27)E 738 50 6 44–50
C0M(873)E 873 3 14 71–86
C0M(1026)E 1026 2 6 50–62
C0M(1176)E 1176 2 5 50–62
C0M(luc)E 1653 0d — Noned
a Titered at 31 h posttransfection. C0M(luc)E had no plaques as of 70 h.
b Plaque areas (N  20–400) for the samples in “a” were averaged
relative to C0ME (2.1 mm diameter). SD for any area was typically less
than 10%.
c Time after transfection (100 ng RNA per 3  106 cells) when 95%
of cells showed lysis or rounding. C0M(luc)E had no CPE after 110 h.
d Assayed separately from rest of panel.
Fig. 3. Plaque size of Mengo vectors. The average plaque sizes of the
viruses are plotted as a function of insert length (Table 2). The “unstable”
inserts are those assessed  or  for insert retention after three to
five passages (Table 3). “Not viable” are those with RNA infectivity 2
PFU per 100 ng (Table 2).
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scripts from pC0M(p27)E, for example, had 70–90%
lower specific infectivity and required twice as long for
complete CPE, compared to parental pC0ME. The identity
of a foreign sequence was not important for these pheno-
types. RNAs from pC0M(mal)E, pC0M(fmd)E, and
pC0M(96)E induced similar plaque patterns and CPE de-
spite having dissimilar insert origins. Further, the enhanced
GFP insert, C0M(Emd)E, gave rise to plaques with similar
area and frequency and induced similar CPE as
C0M(GFP)E and the equivalent length C0M(p27)E. The
Emd sequence differs from normal GFP by at least 14% at
the nucleotide level and 23% in GC content, and neither
sequence shares identity with the SIV p27.
Protein expression in cells
Among the panel of cDNAs were those encoding full-
length genes for CAT, GFP, and SIV p27. When expressed
in the context of C0ME, each of these proteins is flanked
by remnants of the upstream Mengo PCC (4 extra amino
acids), the downstream MCS (7 extra amino acids), and the
EMCV PCC (24 extra amino acids). The extra fragments
had the potential to abrogate the encoded activity or target
the inserted protein for accelerated turnover. Accordingly,
virus from each of these constructs was tested for the ability
to deliver and express its heterologous gene in cells. The
assay for GFP involved examination of infected cells by
confocal microscopy using filters appropriate for GFP flu-
orescence (Fig. 4). Typically, the mock-infected (PBS) and
vC0ME-infected cells showed only sporadic background
signals, while virtually all of the vC0M(GFP)E-infected
cells glowed brightly, indicating the presence of active
protein. Higher magnification (not shown) suggested the
induced GFP localized to cytoplasmic foci, perhaps indicat-
ing the sites of viral translation.
Virus-induced CAT activity from vC0M(CAT)E was
assayed in cytoplasmic extracts (Fig. 5) isolated at various
times postinfection (pi). Again, the mock-infected and
vC0M(p27)E controls showed no activity, while
vC0M(CAT)E-infected cells expressed the active enzyme
in quantities that increased as the infection progressed. CAT
was first detectable at 4 h pi and the activity peaked at about
6 h pi, about the time the cells began to lyse. CAT calibra-
tion standards (Fig. 5, lanes labeled “CAT Units”) and
protein determinations (not shown) suggested there was
about 1 U of CAT activity per 10 g of protein extract at 6 h
pi. This is consistent with what might be expected if most of
the expressed viral polyproteins encoded active CAT en-
zymes.
The SIV p27 protein was detected in plaque Western
assays which required the embedding of infected cells
within thin agar layers that were subsequently overlaid with
nitrocellulose membranes. After incubation to allow plaque
development and protein transfer, the membranes were
probed with antibodies (Fig. 6). Antiserum against SIV gave
strong, dark signals with most of the C0M(p27)E-induced
plaques (panels A and C), confirming the ability of this
vector to express its heterologous gene. However, when the
membranes were stripped and then reprobed with an anti-
body to Mengo 3Dpol (panels B and D), all of the plaques
were positive. The staining dichotomy suggests that the
ability to transmit immunogenic p27 sequences was lost by
a fraction of the viruses as they passaged during plaque
development. The largest, fastest growing plaques presum-
ably originated from parents which lost their p27 inserts
shortly after infection and consequently these plaques ap-
peared only as faint halos when reacted with the anti-SIV
serum.
Protein expression in mice
The successful use of recombinant, short poly(C) tract
Mengo viruses as live, attenuated cardiovirus vaccines in
Fig. 4. GFP expression. HeLa cells grown on glass slides were infected
with C0M’E’, C0M’(GFP)E, or left uninfected (see Materials and meth-
ods). At 3.5 h, the cells were visualized by confocal microscopy using a
fluorescein filter and photographed. Magnification is about 100.
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many species of mammals is well established (Duke et al.,
1990; Osorio et al., 1996a, 1996b), as is the immunogenic
potential of previous Leader-modified Mengo vectors for
primates (Altmeyer et al., 1994). In the interest of a prelim-
inary understanding about C0ME-based vectors’ delivery
of encoded epitopes, mice were inoculated with
C0M(fmd)E, C0M(CAT)E, or with three viruses from
the SIV p27 series of vectors (Fig. 7). Despite the small size
of the FMD insert (27 amino acids plus 35 from the vector),
Fig. 5. CAT expression. HeLa cells were infected with C0M’(p27)E’ or C0M’(CAT)E’ (see Materials and methods). At the indicated times pi, samples were
harvested, lysed, and then assayed for CAT activity. The chloramphenicol reactant (bottom spots) and acetyl-chloramphenicol products (top spots) were
separated by thin-layer chromatography. The reactant:product ratio (% product) was quantitated after fluorimaging. Reference samples (left lane) and control
reactions with standard CAT (0.1, 0.5, and 1.0 units) were included. The four right-hand lanes show similar assays (and control) with brain extracts from
an uninfected mouse, or mice inoculated with C0M’E’ or C0M’(CAT)E’ virus, as under Materials and methods.
Fig. 6. Plaque Western assays. HeLa cells were infected with C0M’(p27)E’
virus and plated into soft agar (see Materials and methods). Nitrocellulose
membranes exposed to the agar for 10 h (C and D) or 20 h (A and B) were
reacted with an SIV-specific polyclonal serum and then reacted with a goat
anti-human antibody, conjugated with horseradish peroxidase, to visualize
the plaques containing immunogenic material (A and C). The membranes
were then stripped and reacted with a murine monoclonal antibody to
Mengo 3D, followed by goat anti-mouse antibody, conjugated with horse-
radish peroxidase (B and D), as a control for Mengo protein expression.
The dichotomy between light plaques (A and C) and total plaques (B and
D) is an indication of insert stability during plaque development.
Fig. 7. Immunogenic responses. (A) Pre- and postimmunization sera (light
and dark bars, respectively) from vMC0- and M’(fmd)E’-inoculated mice
were tested in slot blot assays for immunoreactivity with a synthetic 27
amino acid FMDV VP1 peptide, the same as that encoded by M’(fmd)E’,
as described under Materials and methods. (B) Groups of mice were
inoculated with PBS (white bars), M’E’, or the indicated p27-containing
Mengo vectors (dark bars) as described under Materials and methods. The
ELISA reactivity of serum from each animal, against a p27 peptide, are
shown, as are the average values for each group.
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each of the three intraperitoneally (ip) inoculated animals
developed serum titers that reacted significantly more
strongly with a synthetic FMDV peptide in slot blot assays,
than preimmune serum, or with serum from a vMC0 inoc-
ulated animal (Fig. 7A). The same was true for the p27
vectors administered intramuscularly (im), in that serum
from nearly every inoculated animal showed strong ELISA
reactivity with a purified p27 protein. The average ELISA
values were 1.8 to 3.3 times higher than for serum from
PBS- or C0ME-inoculated control animals, and some in-
dividuals (e.g., mouse 15 and 21) had much stronger signals
(Fig. 7B). The C0M(CAT)E vector was also chosen for
preliminary intracranial (ic) testing, because of the simple,
sensitive nature of the enzyme assay. In this case CAT
activity was detected in a homogenized brain lysate, har-
vested 24 h after ic inoculation of virus, but not in an
equivalent extract from an animal that received the parental
C0ME virus, or from an uninfected animal (Fig 5). To-
gether these data reiterate the ability of these attenuated
vectors to deliver biologically active and immunologically
relevant proteins into animals as well as cell culture.
Insert stability
A key consideration in delivery efficacy for any vector is
the preparation of genetically stable viral stocks. The plaque
Western assays with C0M(p27)E and the sporadic devel-
opment of heterogeneous plaques with the largest insert
sequences (Table 2) were suggestive of passage-dependent
viral selection for deleted or trimmed insertions. These
trends seemed to be exacerbated whenever the vectors were
passaged at high m.o.i. or the transfections were initiated
with excessive RNA (not shown). Clearly, if an insert cre-
ated a genetic load that worked against virus propagation,
then genomes shorter than some critical length should be
favored and progressively dominate the cultures. To mea-
sure the threshold length of insert stability, RNAs from
pC0ME and 19 other plasmids were transfected into HeLa
cells using a large ratio of RNA:cell to accelerate the ob-
servation of fast growing progeny. As each sample reached
CPE (see Table 2), the cells were lysed and the population
of progeny virus (passage 1) was used to infect another
monolayer. Viral RNA extracted after each of three to five
sequential blind passages was tested by RT-PCR using
primers diagnostic for deletion events within or between the
duplicate PCCs. The resulting amplicons confirmed that the
entire panel of smaller inserts (500 bases) was reasonably
stable to passage (Fig. 8). The first through fifth generation
progeny, including that from vC0M(474)E, produced
dominant fragments consistent with their expected inser-
tions and which comigrated with fragments programmed by
their respective, parental RNAs (lanes labeled “0”).
In contrast, viruses carrying larger inserts began to am-
plify heterogeneous progeny even within the earliest pas-
sages. As an example, full-length vC0M(594)E could be
detected in all five passages, but genomes with partially
deleted inserts arose by passage 2 and these species were the
majority genotypes in later passages. In this particular case,
progeny with inserts of (approximately) 375, 275, 150, 75,
and -100 bases dominated the final culture (Fig. 8 and Table
3). This last fragment, measured relative to vC0ME, is
consistent with a recombination event that excised one of
the flanking PCCs as well as the entire insert. Parallel
experiments with larger vectors showed even faster accu-
mulation of deleted sequences. Vector pC0M(618)E is
only 24 bases longer than pC0M(594)E, but a variety of
recombinants was already evident within the first trans-
fected cells. After five passages, inserts with (approxi-
mately) 450, 375, 275, 75, 0 and -100 bases (again, probably
a PCC deletion) were the prevalent species, and the small
population with full-length inserts was detectable only by
additional reactions with special insert-specific primers.
The rapid selection for deleted sequences was so domi-
nant among the largest vectors (i.e., inserts of 700 bases)
that the serial transfers were usually stopped after three
passages when the signals from the full-length inserts were
virtually negligible in assays with the standard flanking
primers. More sensitive assays with insert-specific primers
showed that, in fact, every construct except C0M(1176)E
had managed to maintain some minimum level of full-
length insert during the first passage, including the vectors
carrying 873 or 1026 foreign bases (Table 3). However, by
the end of the third passage, inserts larger than 750 bases
were rarely detected. Instead, populations of viruses with
smaller, albeit significant, fragments of their engineered
insertions overgrew the cultures. As long as these deleted
genomes did not carry more than about 600 nonviral bases,
the new recombinants passaged with fidelity and apparent
stability during subsequent rounds, and in a manner similar
to passage of the smaller vectors from the original panel.
Discussion
Safely, potency, immune duration, host range, genetic
stability, and cost are just some of the considerations in the
development of effective new vaccines and vaccine vectors.
Our interest in the carrying capacity of cardioviruses paral-
lels advances with other picornaviruses, in that we would
like to exploit known vaccine successes toward new gener-
ations of effective reagents. EMCV and Mengo are similar
to other picornaviruses in that they are easily neutralized by
antibodies directed against the capsid proteins (Boege et al.,
1991). Vaccines formulated from inactivated virions are
usually protective, but protection tends to be B cell specific
and short lived in the host (Altmeyer et al., 1994). Live-
attenuated viruses, on the other hand, as typified by the
polio Sabin strains and our recombinant variants of poly(C)-
deleted Mengo, can confer longer lived immunity that elic-
its both cellular and humoral responses (Hubbard et al.,
1992; Backues et al., 1999). Moreover, live strains do not
require the administration of adjuvants to boost effective-
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ness and they have the added potential of auxiliary re-
sponses against viral nonstructural proteins.
During the last decade, many creative techniques have
tried to harness these responses by developing chimeric
genomes that piggy-back foreign genes or epitopes into live
picornavirus vectors. One promising strategy replaced the
exposed capsid epitopes of poliovirus (Altmeyer et al.,
1991; Jenkins et al., 1990), rhinovirus (Arnold et al., 1994,
1996; Smith et al., 1998), or TMEV (Zhang et al., 1995)
with small exogenous peptides. Regrettably, many of these
insertions seemed to interfere with capsid assembly pro-
cesses and reduced the viral fecundity. Only a few such
viruses were shown to induce high levels of protective
antibodies. Another vector approach employed bicistronic
polio genomes with secondary internal ribosome entry sites
that could translate foreign genes independently of the viral
genes (Alexander et al., 1994; Lu et al., 1995). These clever
creations successfully synthesized proteins within infected
cells, but again, the extra sequences plus the required ge-
netic space for the second IRES (about 450 bases) combined
to impair the overall viral growth rates and only small
inserts were stably carried during serial passage. Multiple
related vector strategies have tried to engineer direct fusions
between the foreign genes and the viral reading frame, with
a reliance on natural or duplicated 2A or 3C protease rec-
ognition sites to cleave the insert from the polyprotein, and
there are various descriptions of replicating chimeric polio-
viruses carrying insertions of 700–1100 bases (Andino et
al., 1994; Zhang et al., 1995). Other reports, however, have
estimated the carrying capacity to be closer to 300 bases
using this method (Mattion et al., 1994, 1995), and the
practical utility of polio fusion vectors has been questioned
for the expression of greater than 10 kDa, or roughly 90
amino acids (Mueller and Wimmer, 1998), because of the
propensity for reversion.
The genome organization of EMCV and Mengo differs
in significant ways from the polioviruses (Enterovirus) and
Rhinoviruses, the centered targets of most previous vector
efforts. In particular, engineered deletion of the long, car-
diovirus 5 poly(C) tract, which can occupy up to 450 bases
in some natural strains of virus (Black et al., 1979; Palmen-
berg and Osorio, 1994), raised the possibility that vMC0-
based viruses might have the capacity to tolerate much
longer heterologous insertions than other species of picor-
naviruses. Moreover, the self-contained primary cleavage
reaction, another unusual feature of cardioviruses, offered a
Fig. 8. Insert stability during serial passage. Transfected HeLa cells (1 g RNA per 3  106 cells) were incubated to complete CPE. Viral stocks (passage
1) were harvested, titered, and then blind-passaged again (m.o.i. of 10) for two to four additional cycles. Virion RNA from each passage was used to program
RT-PCR (see Materials and methods). The products were visualized after agarose gel fractionation. Lane designations (1–5) represent the passage number
from which the virus was isolated. Passage “0” samples were programmed with transcript RNA. Size markers (M) were included in each gel.
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potential new mechanism by which all viral genes might be
precisely and effectively expressed via their normal termini,
despite the insertion of additional, heterologous genes. The
goal of the current Mengo project was to test whether
duplication of the autocatalytic primary cleavage cassette
might actually provide a more stable and useful platform for
the insertion of foreign sequences than the previous Leader
insertion vectors. We found that tandem PCCs could indeed
fire efficiently during viral protein synthesis. Primary pro-
cessing at either site was not significantly affected by het-
erologous insertion between the PCCs, regardless of size or
sequence origin. Moreover, the capsid and replication pre-
cursors produced by these cleavages were processed nor-
mally by 3Cpro. After RNA transfections, all except the very
largest vector, C0M(luc)E, produced viable viruses. For-
eign genes such as GFP, CAT, and SIV p27 were expressed
at high levels in cell-free extracts and cell culture and the
insert stability was significantly improved relative to Leader-
based Mengo vectors.
However, as with all other picornaviral vectors (Mattion
et al., 1994, 1995, 1996; Yim et al., 1996), the growth
characteristics and genetic stability of the C0ME panel
was found to be highly dependent on insert size. The effi-
ciency of replication as measured by plaque formation
clearly declined as the insert size increased, with the relative
plaque area dropping about 10% for every 75 added bases.
Vector C0ME could carry foreign genes as large as 1000
bases (not including 111 bases from the MCS and the
EMCV PCC), but inserts larger than about 600 bases were
generally unstable during forced passage at high m.o.i. and
always resulted in faster growing viruses that dominated the
cultures within two to three passages. To be sure, many of
the large inserts, similar to C0M(GFP)E, could be care-
fully passaged with apparently improved stability if smaller
amounts of RNA were used to initialize the transfections or
if the cells were infected at low m.o.i. (not shown), but such
measures are not practical for routine virus propagation, and
we consider the realistic carrying capacity of C0ME to
peak at a maximum of 500–600 foreign bases.
One surprise in these experiments, perhaps confirming
this threshold capacity, is that the majority of deleted re-
combinants, once they arose, failed to completely remove
the foreign gene. Populations with initial large insertions
passaged with stability once their internal fragments had
been whittled down to about 450 bases by partial reversion.
Most picornavirus recombination mechanisms invoke reac-
tions between direct repeats (Mueller and Wimmer, 1998;
Pilipenko et al., 1995) and the duplicate PCCs are de facto
long repeats with about 70% identity. Therefore, we had
expected wild-type revertants to dominate the progeny by
recombination between the PCCs. While a few such ge-
nomes were observed (Table 3) and confirmed by sequenc-
ing (J.J. Binder and A.C. Palmenberg, manuscript in prep-
aration), these viruses were not the prevalent species and
they passaged as minorities in populations that also included
multiple larger sequences. It is possible that progeny stabil-
ity could be somewhat enhanced in future constructions by
replacing the EMCV PCC with equivalents from FMDV
and TMEV, or by engineering additional silent mutations
into the second PCC. However it is already apparent that
once the genome length became truncated below the critical
length, the selective pressure for further deletion was sig-
nificantly reduced.
Creative engineering or culture techniques (e.g., low
passage number) may eventually develop more tricks to
increase the practical carrying capacity of live picornavirus
vectors. The genome size can only be pushed so far, how-
ever, since the fixed volume of natural capsids will always
be a limiting factor and was probably the key reason for
reduced fecundity by our largest inserts. Previous work with
polio showed that genomes extended by 17%, but not 31%,
could be recovered as infectious virions (Lu et al., 1995),
but packaging and assembly problems were common even
with much smaller inserts (Mattion et al., 1995; Tang et al.,
1997; Yim et al., 1996). Likewise with Mengo, the largest
inserts seemed to impinge upon the assembly and stability
of particles. RNA from C0M(luc)E translated and repli-
cated efficiently upon transfection, but failed to form infec-
Table 3
Genetic stability of insertions
Vector Insert
retention
pass 1a
Insert
retention
pass 3 or 5b
Retained fragment(s)
(bases)c
C0ME   (0)
C0M(mal)E   (50)
C0M(fmd)E   (75)
C0M(96)E   (100)
C0M(189)E   (200)
C0M(225)E   (225)
C0M(336)E   (325)
C0M(378)E   (375)
C0M(456)E   675, (450), 125, 0
C0M(474)E   (475)
C0M(594)E   (600), 375, 275, 150,
75, 100
C0M(618)E   (625), 450, 375, 275,
75, 0, 100
C0M(GFP)E   100, 25, 100
CM(GFP)E   75, 0
C0M(Emd)E   275
CM(Emd)E   200, 125, 50, 50
C0M(p27)E   (750), 100, 25
C0M(873)E   450, 375, 275, 0,
100
C0M(1026)E   250, 25, 100
C0M(1176)E   375, 200
a RT-PCR reactions on cell lysates after RNA transfection are described
under Materials and methods. Parental insert was () major band;
() minor band; () detectable only with insert-specific primers; ()
undetectable.
b RT-PCR assays as in “a” were repeated after three (GFP and larger
vectors) or five (smaller vectors) serial passages.
c Size estimate relative to C0ME (from Fig 8, rounded to nearest 25 b)
of dominant insert population(s) after three or five serial passages. Paren-
theses indicate comigration with parental insert.
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tious particles, presumably because this genome, 23% larger
than vMC0, was packaged ineffectively. Even when pack-
aging did occur with the large recombinants, such as
C0M(p27)E, the infectious stocks tended toward thermo-
lability, losing infectivity more quickly at elevated temper-
atures than parental virus lacking inserts (data not shown),
suggesting the capsids were physically strained. If this is
true, no additional engineering can bypass this evolutionary
constraint on maximum picornavirus length. Any Mengo
vector with a genome larger than about 8500 bases, inclu-
sive of the poly(A), poly(C), and engineered insert, is likely
to be disadvantaged during multiple infectious passages.
Nevertheless, with the ubiquitous host range and strong
attenuation conferred by poly(C) deletions, the collective
data still point to C0ME as a potent vehicle for the delivery
of heterologous proteins that do not exceed 200 amino acids
in length.
The ability of this novel cardiovirus vector to stimulate
insert-specific immune responses in animals is still under
investigation. Although much work remains to be done,
particularly with regard to the optimization and judicious
selection of potent immunogens, the initial animal data
presented here are encouraging in that they show that
epitopes as small as 27 amino acids from C0M(fmd)E, or
as large as 246 amino acids from C0M(p27)E, could direct
humoral responses after ip or im innoculation of mice (Fig.
7). Moreover, expressed CAT activity (219 amino acids)
was detected in the brains of animals innoculated (ic) with
C0M(CAT)E virus (Fig. 5), suggesting these preparations
retained and delivered their genetic cargo in the context of
intact and biologically relevant proteins.
Materials and methods
Engineered genomes
Standard recombinant DNA techniques were used (Sam-
brook et al., 1989; Ausubel et al., 1993). Mengo cDNAs
encoding duplicate PCC were constructed stepwise. First, a
513-bp cDNA fragment encompassing the Mengo 2A/2B-
encoding region was excised from full-length Mengo plas-
mid, pMC0 (Martin et al., 1996), and subcloned into a
pBS vector (Stratagene). Next, a MCS with NheI, HpaI,
and SunI sites was created by annealing complimentary
primers (5 CATGCTAGCGTTAACCGTACG 3 and 5
CATGCGTACGGTTAACGCTAG 3) and by inserting the
fragment into an NcoI site upstream of the Mengo PCC. The
204-bp BstEII-PmeI fragment from this plasmid was cloned
back into the same cDNA at the PmeI site, creating a MCS
flanked by duplicate, in-frame copies of the Mengo PCC.
Finally, the downstream Mengo PCC (174 bp) was excised
and replaced with a homologous EMCV amplicon (84 bp)
derived from full-length plasmid, pEC9 (Hahn and Palmen-
berg, 1995). The EMCV amplicon maintained 70% base
identity to Mengo over the PCC length and was flanked by
SunI and PmeI sites introduced by the primers. The dupli-
cated Mengo PCC fragment (MM) and the duplicated
Mengo-EMCV PCC fragment (ME) were excised from
their respective subclones by BstEII and AflII digestion and
used to replace the (single) PCC in pMC0 that had been
similarly digested. Full-length Mengo plasmids, pC0MM
and pC0ME, each have two PCCs flanking a MCS. They
maintain the complete viral polyprotein reading frame and
have deleted (C0) 5 poly(C) tracts (Fig. 1).
Thirteen PCR amplicons encoding non-Mengo cDNA
fragments were synthesized and inserted into the MCS of
plasmid pC0M’E’ by a common protocol. The PCR tem-
plates (Table 1) included the following: SIV p27 cDNA
from a biological isolate of SIVmac251 (courtesy of Dr.
David Pauza, University of Maryland, Institute of Human
Virology); plasmid pGFP-TT encoding a doubly mutated
form (S65T, II67T) of green fluorescent protein (GFP; cour-
tesy of Dr. Yoshi Jin); plasmid peGFPemd(c) designed for
enhanced eukaryotic expression of GFP activity (Emd;
Packard); and plasmid pSV2CAT encoding the chloram-
phenicol acetyl-transferase gene (CAT; Stratagene). In all
cases, NheI and SunI restriction sites were encoded in the
amplification primers. The specific priming locations rela-
tive to templates were chosen to provide a stepwise range of
amplicon sizes. After gel separation and purification (Qia-
quick gel extraction kit, Qiagen), the fragments were an-
nealed with and then ligated (T4 DNA ligase, New England
Biolabs) into pC0M’E’ that had been digested with NheI and
SunI.
Additional cDNAs, pC0M’(873)E’, pC0M’(1026)E’, and
pC0M’(1176)E’, linked various size fragments of the GFP
gene to the complete SIV p27 gene. The GFP amplicons
were synthesized using primers encoding NheI and SacI
sites. An SIV p27 amplicon (with SacI- and SunI-containing
primers) was ligated to the various GFP fragments after
mutual digestion with SacI. After PCR amplification and gel
purification, the linked fragments were digested with NheI
and SunI, repurified, and then ligated into similarly digested
pC0M’E’.
Mengo cDNA, pC0M’(mal)E’, encoded a CTL epitope
(13 amino acids) from the circumsporozoite protein of Plas-
modium yoelli (murine malaria). Complementary primers
(5 CTAGCGAATGAAGATTCTTACGTACCAAGCGC-
GGAACAAATA 3 and 5 CTAGTATTTGTTCCGCGCT-
TGGTACGTAAGAATCTTCATTCG 3) were annealed to
produce a fragment with NheI-compatible overhanging
ends. The fragment was inserted into the NheI site of a
pC0M’E’ subclone before the insert and duplicate primary
cleavage region were transferred into full-length pC0M’E’.
This plasmid was a generous gift from Dr. Harry Hahn.
Mengo cDNA, pC0M’(fmd)E’, encoded the antigenic
VP1 GH loop segment (27 amino acids) from foot-and-
mouth-disease virus, strain A12. A synthetic, single-strand
of cDNA (78 bases) was synthesized according to the se-
quence in GenBank (Accession No. M10975) and then used
as a template for PCR amplification with NheI and SunI-
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containing primers. The amplicon was digested with NheI
and SunI and ligated into similarly digested pC0M’E’.
Mengo cDNA, pC0M’(luc)E’, encoded a firefly lucif-
erase gene (551 amino acids). The luciferase fragment from
pMLuz (Duque and Palmenberg, 2001) was amplified by
PCR using NheI- and Acc 65I -containing primers. The
amplicon was digested with NheI and Acc65I and then
ligated into pC0M’E’ cDNA that had been digested with
NheI and SunI.
Plasmid pMwt, encoding a virulent strain of Mengo with
a 5 poly(C) of C44UC10, has been described (Martin et al.,
1996). The GFP genes and surrounding primary cleavage
cassettes from pC0M’(GFP)E’ and pC0M’(Emd)E’ were
transferred into pMwt via restriction fragment exchange
using appropriate enzymes [BlnI and AgeI for
C0M’(GFP)E’ and BlnI and BamHI for pC0M’(Emd)E’].
The resulting plasmids were designated pCM’(GFP)E’
and pCM’(Emd)E’, respectively.
After transformation of Escherichia coli strain MV1190,
using heat shock, all of the above-described plasmids were
purified (Maxiprep kit, Qiagen) and then characterized by
restriction analyses and sequencing, using a manual method
(T7 Sequenase, Amersham), or an automated method (ABI
sequencer models 377XL or 377-96).
RNA methods
Viral plasmids were treated with BamHI or SalI (7–20 U,
4.5 h at 37°C), which cleave at 3 or 16 bases 3 to the viral
poly(A), respectively. Linearized cDNA (2 g) was col-
lected (PCR purification kit, Qiagen), dried, and then resus-
pended in H2O (4 l) before use as a transcription template
with T7 RNA polymerase (7.5 U for 2 h at 37°C, Gibco-
BRL) in reactions that contained DTT (28 mM), rNTPs
(1.56 mM each), and RNase inhibitor (40 U, Promega).
After treatment with DNase (10 U, 20 min, 37°C), the RNA
was isolated (RNeasy kit, Qiagen, or by phenol–chloroform
extraction with ethanol precipitation) and then resuspended
in H2O. Transcript samples were characterized for size and
concentration after agarose gel fractionation.
Viral RNA was recovered from infected or transfected
cell lysates (180 l) by addition of SDS (20 l, 10%) and
phenol:chloroform (200 l, 1:1), heat treatment (55°C for 3
min), and chilling (to 4°C). The samples were clarified
(16,000 g, 3–4 min), reextracted with phenol:chloroform
and then clarified with chloroform:isoamyl alcohol (24:1).
The RNA was precipitated with ethanol (80°C) in the
presence of ammonium acetate, collected (16,000 g, 15
min), washed (70% ethanol), dried, and then resuspended in
H2O (15 l). To characterize the viral sequences, the puri-
fied RNA (5 l) was incubated with (70°C, 5 min) and then
annealed (4°C) to a primer (19 bases) complementary to
bases within the Mengo 2B region. M-MLV RTase (200 U,
Gibco-BRL) was reacted with the sample (9 mM DTT, 0.83
mM dNTP, 0.4 U RNase inhibitor, 41°C, 75 min) before
Tris–EDTA buffer was added (80 l). Subsequent PCR
with PFU DNA polymerase (Stratagene) used pairs of
Mengo-specific primers flanking the M’ and E’ primary
cleavage cassettes, or insert-specific primers chosen for
each heterologous sequence. The amplicons were fraction-
ated on agarose gels in the presence of size markers and
visualized after staining with ethidium bromide.
Virus growth
HeLa cells were grown to confluent monolayers (3 106
cells per 60 mm plate) at 37°C under 5% CO2. Transcript
RNA (0.1–1.0 g) was mixed with liposomes (Rose et al.,
1991) containing RNase inhibitor (4 U) in Hanks balanced
salt solution (HBSS, 4°C). The monolayers were washed
with phosphate-buffered saline (PBS, 20°C), then HBSS,
and incubated with the transfection mix (250 l) for 30 min
at 20°C. For plaque assay experiments, the transfected cells
were rinsed with PBS and then overlaid with agar (2.5 ml of
0.8% noble agar in P5 media). A liquid overlay (2.5 ml, P5
media with 1 gutamine-oxalacetic acid-pyruvic acid so-
lution, 0.2% dextrose) was added after the agar hardened.
The plates were transferred to 37°C, under 5% CO2 (Rueck-
ert and Pallansch, 1981). After at least 29 h of incubation,
the cells were washed and stained with crystal violet for
plaque visualization. Plaque areas (pixels2) were measured
(Imagequant software, Molecular Dynamics) after the plates
were scanned.
Blind passage experiments were similar, except the liq-
uid overlay (5 ml without agar) was added to the transfected
cells (1.0 g RNA per plate) after the first PBS wash, and
the plates were incubated at 37°C until cytopathic effect
(CPE) was complete (24–86 h). Viral stocks were obtained
by subjecting the monolayers to freeze/thaw (three cycles)
and clarification of the lysates (2000 g for 2–5 min). After
plaque assays (as above) to determine the titer, the stocks
were reinfected into fresh monolayers (m.o.i. of 10 PFU/
cell) for a second, third, fourth, or fifth serial passage. All
stocks were characterized for virion RNA content.
Protein expression assays in cells
Cell-free translation reactions in rabbit reticulocyte ex-
tracts (15 l) using [35S]Met label and RNA transcripts
were as described previously (Pelham, 1978; Duke et al.,
1992). After the reactions were complete (2 h at 30°C), two
or four aliquots (1 l each) from each sample were assayed
for acid insoluble [35S]Met incorporation (Palmenberg and
Rueckert, 1982). Additional samples were fractionated by
SDS–PAGE (13.5% Laemmli gels); the gels were dried and
the bands were visualized by autoradiography.
GFP activity was monitored after infection (m.o.i. of 10)
of HeLa cells (3.5  105) that had been plated on glass
slides (Nunc). The virus and cells were coincubated for 30
min (20°C) before the slides were covered with liquid over-
lay (2 ml) and then further incubated (37°C, 3–4 h) in small
chambers under 5% CO2. Coverslips were applied after the
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slides were washed (PBS), and then protein fluorescence
was visualized by confocal microscopy (Bio-Rad model
MRC-600 with fluorescein filter). Virus for this experiment
was plaque purified after transfection (100 ng RNA per 3 
106 cells) with pC0M’(GFP)E’ transcripts.
CAT assays were performed on infected cell extracts ac-
cording to the manufacturer’s protocol (Stratagene). Briefly,
HeLa cells (3 106 on 60 mm plates) were infected with virus
(m.o.i. of 6) as described for blind passage assays. At appro-
priate intervals, plates were removed from the incubator,
washed twice with PBS, and then scraped to collect the cells
(into 1 ml PBS). After pelleting (10,000 g, 10 min, 4°C) and
resuspension in CAT reaction buffer (100 l, 0.25 M Tris pH
7.4), the cells were subjected to three cycles of freeze/thaw
(dry ice/ethanol bath) and then clarified by centrifugation
(16,000 g, 10 min, 4°C). The supernatant protein concentra-
tions were measured (DC Protein Assay, Bio-rad), and then
equal portions (10 g in 55 l) were mixed with acetyl Co-A
(10 l, 20 mM) and BODIPY-labeled chloramphenicol (15
l). After 1 h at 37°C, the samples were extracted with ethyl
acetate (1 ml, 0°C), dried under vacuum, and then resuspended
in ethyl acetate (30 l). Aliquots (5 l) were spotted onto
thin-layer silica gel plates (Whatman) and subjected to chro-
matography in a tank equilibrated with chloroform:methanol
(87%:13%). The reactants were visualized by fluorimaging
(Molecular Dynamics) and quantitated (Imagequant). To mea-
sure CAT responses in animals, 6-week-old ICR Swiss mice
were inoculated ic with C0M’E’ or C0M’(CAT)E’ virus (10l,
1 106 PFU). At 24 h pi, the animals were euthanized. Brain
tissue was extracted, homogenized into a 10% suspension,
clarified by centrifugation as described (Osorio et al., 1996b),
and then subject to CAT detection as described above.
SIV p27 expression was measured in plaque Western
assays. HeLa cells (1–5  107 cells per plate) suspended in
P5 media were mixed with virus (m.o.i. of 10–100 PFU) for
30 min at 20°C. Melted agar (5.1 ml) was added and the
mixture was spread onto plates (100 mm) that already con-
tained a warm layer of hard agar (15 ml). The plates were
covered, inverted, and incubated (49 h, 37°C, 5% CO2)
before nitrocellulose membranes (85 mm, Millipore) were
applied to the agar surface and incubation continued. After
10–20 h the membranes were removed and then developed
in ECL Western assays according to the manufacturer’s pro-
tocol (Amersham-Pharmacia). Primary antibodies included
macaque, polyclonal anti-SIV serum (1/5000 dilution, courtesy
Dr. David Pauza), or a murine IgG2A monoclonal 8D10-3c3c,
developed against Mengo 3D polymerase (Duque and Palmen-
berg, 1996) (ascites, 1/5000 dilution). The secondary antibod-
ies (conjugated with horseradish peroxidase) were goat anti-
human or goat anti-mouse IgG (1/5000 dilution), respectively.
Serum neutralization assay
Mengo-specific neutralizing antibodies were measured
by a serum neutralization assay. Mouse serum was initially
diluted 1:10 in Medium A. Serial twofold dilutions down to
1:640 were performed in 96-well tissue culture plates. Wild-
type Mengovirus (1  104 PFU) was incubated with the
serum dilutions at 37°C for 1 h. HeLa cells (5  104 per
well in 100 l of Medium A) were added to each virus/
serum mixture. Plates were incubated at 37°C for 31 h to
allow plaque formation. Cells were stained overnight with
crystal violet to show plaques.
Murine response p27 vectors
Virus stocks [C0M’E’, C0M’(474)E’, C0M’(594)E’,
C0M’(p27)E’] were isolated from plaques arising after RNA
transfection of HeLa cells (as above) and amplified by a
single blind passage (see above). Six-week-old, female
BALB/C mice (Jackson Laboratory) were divided into five
groups. Three mice were injected im with PBS (100 l).
Three mice were immunized with 1  107 PFU of C0M’E’
(100 l, im). Three groups of five mice were immunized
with 1  107 PFU of C0M’(474)E’ (100 l), C0M’(594)E’
(175 l), or C0M’(p27)E’ (100 l). On day 15 pi, animals
were bled from the retroorbital plexus and boosted with
equivalent doses of the same viruses. On day 30 pi, animals
were again bled and boosted with equivalent doses of the
same viruses. Animals were bled one final time 15 days
after the last boost. Serum was isolated from blood cells by
centrifugation in microtainer tubes. During the experiment,
three mice died from overanesthetization, one each from the
PBS, C0M’(474)E’, and C0M’(594)E’ groups. SIV p27-
specific antibodies were detected by enzyme-linked immu-
nosorbent assay (ELISA). Briefly, medium-binding ELISA
plates were coated (4°C, 12 h) with purified recombinant
SIV p27 (1 g protein, courtesy Dr. David Pauza, in 100
g, in 70 mM sodium bicarbonate, 30 mM sodium carbon-
ate, pH 9.6). Wells were rinsed with water and blocked for
1–2 h with 1% casein in PBS. Diluted mouse serum was
added to the blocking buffer and incubation was continued
for an additional 2 h. Wells were washed three times with
PBS-T. Horseradish peroxidase conjugated goat anti-mouse
Ig (1/2000 dilution, Sigma) was incubated in the wells (1 h,
37°C). Wells were washed three times with PBS-T, twice
with water, and once with substrate buffer (25 mM sodium
citrate, 50 mM sodium phosphate, pH 5.0). Substrate solu-
tion (5 mg of O-phenylenediamine in 12 ml of 25 mM
sodium citrate, 50 mM sodium phosphate, 0.03% hydrogen
peroxide, pH 5.0) was added to the wells and incubation
was continued for 1 h. Reactions were stopped with 5%
H2SO4(50 l). ELISA reactivity was measured spectropho-
tometrically at 492 nm in an automated plate reader (Bio-
Tek Instruments).
Murine response to FMD vector
RNA transcripts encoding C0M’(fmd)E’ and vMC0 were
transfected into HeLa cells. Isolated plaques were selected
and the viruses were amplified in HeLa cells. Viral stocks
were harvested by three cycles of freezing and thawing. Cell
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debris was removed by centrifugation. Virions were purified
by pelleting through 30% sucrose cushions and diluted to
the appropriate concentrations in PBS. One female BALB/C
mouse was immunized ip with vMC0 (100 l, 1  106
PFU). Three female BALB/C mice were immunized ip with
C0M’(fmd)E’ (100 l, 1 106 PFU). On day 26 pi, animals
were boosted ip with equivalent doses of the same viruses.
Four weeks after the boost, animals were bled from the
retroorbital plexus, and serum was isolated after centrifuga-
tion in microtainer tubes. FMDV-specific antibodies were
detected by slot blot. Briefly, samples of purified FMDV
peptide (2 g, courtesy of Dr. Fred Brown) were adsorbed
onto a Millipore Immobilon-P membrane. The membrane
was blocked and incubated with pre- and postvaccination
serum (1/100 dilution) and then washed and incubated with
horseradish peroxidase conjugated anti-mouse antibodies
(1/2000, polyclonal). A colorimetric substrate was added to
detect secondary antibodies. The membrane was scanned
into a computer and signal intensity was measured using
Imagequant software.
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